AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
FACTORS AFFECTING MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH LYMPHOMA
Authors: MOSKOWITZ CH GLASSMAN JR WUEST D MASLAK P REICH L GUCCIARDO A COADYLYONS N ZELENETZ AD NIMER SD
Citation: Ch. Moskowitz et al., FACTORS AFFECTING MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH LYMPHOMA, Clinical cancer research, 4(2), 1998, pp. 311-316
FACTORS AFFECTING MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH LYMPHOMA
Authors: MOSKOWITZ CH GLASSMAN JR WUEST D MASLAK P REICH L GUCCIARDO A COADYLYONS N ZELENETZ AD NIMER SD
Citation: Ch. Moskowitz et al., FACTORS AFFECTING MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH LYMPHOMA, Clinical cancer research, 4(2), 1998, pp. 311-316
WESTERN STUDY OF ARSENIC TRIOXIDE (AS2O3) IN PATIENTS WITH RELAPSED AND OR REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA/
Authors: SOIGNET SL MASLAK P CHEN YW CALLEJA E PANDOLFI PP SCHEINBERG DA WARRELL RP
Citation: Sl. Soignet et al., WESTERN STUDY OF ARSENIC TRIOXIDE (AS2O3) IN PATIENTS WITH RELAPSED AND OR REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA/, Annals of oncology, 9, 1998, pp. 675-675
A PHASE-I TRIAL OF A SINGLE HIGH-DOSE OF IDARUBICIN COMBINED WITH HIGH-DOSE CYTARABINE AS INDUCTION THERAPY IN RELAPSED OR REFRACTORY ADULTPATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: WEISS MA DRULLINSKY P MASLAK P SCHEINBERG D GOLDE DW
Citation: Ma. Weiss et al., A PHASE-I TRIAL OF A SINGLE HIGH-DOSE OF IDARUBICIN COMBINED WITH HIGH-DOSE CYTARABINE AS INDUCTION THERAPY IN RELAPSED OR REFRACTORY ADULTPATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia, 12(6), 1998, pp. 865-868
IMMUNOPHENOTYPIC ANALYSIS IN HEMATOLOGIC ONCOLOGY
Authors: MASLAK P
Citation: P. Maslak, IMMUNOPHENOTYPIC ANALYSIS IN HEMATOLOGIC ONCOLOGY, Journal of tumor marker oncology, 13(3), 1998, pp. 25-34
THE EFFICACY OF IL-3, SCF, IL-6, AND IL-11 IN TREATING THROMBOCYTOPENIA
Authors: MASLAK P NIMER SD
Citation: P. Maslak et Sd. Nimer, THE EFFICACY OF IL-3, SCF, IL-6, AND IL-11 IN TREATING THROMBOCYTOPENIA, Seminars in hematology, 35(3), 1998, pp. 253-260
COMPLETE REMISSION AFTER TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ARSENIC TRIOXIDE
Authors: SOIGNET SL MASLAK P WANG ZG JHANWAR S CALLEJA E DARDASHTI LJ CORSO D DEBLASIO A GABRILOVE J SCHEINBERG DA PANDOLFI PP WARRELL RP
Citation: Sl. Soignet et al., COMPLETE REMISSION AFTER TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ARSENIC TRIOXIDE, The New England journal of medicine, 339(19), 1998, pp. 1341-1348
COMPLETE REMISSION AFTER CLINICALLY INDUCED-DIFFERENTIATION AND APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA BY ARSENIC TRIOXIDE
Authors: SOIGNET SL MASLAK P CHEN YW CALLEJA E PANDOLFI PP SCHEINBERG DA WARRELL RP
Citation: Sl. Soignet et al., COMPLETE REMISSION AFTER CLINICALLY INDUCED-DIFFERENTIATION AND APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA BY ARSENIC TRIOXIDE, British Journal of Haematology, 102(1), 1998, pp. 225-225
POTENTIATION OF APOPTOSIS BY FLAVOPIRIDOL IN MITOMYCIN-C-TREATED GASTRIC AND BREAST-CANCER CELLS
Authors: SCHWARTZ GK FARSI K MASLAK P KELSEN DP SPRIGGS D
Citation: Gk. Schwartz et al., POTENTIATION OF APOPTOSIS BY FLAVOPIRIDOL IN MITOMYCIN-C-TREATED GASTRIC AND BREAST-CANCER CELLS, Clinical cancer research, 3(9), 1997, pp. 1467-1472
AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (APBPCT) USING INCREASED DOSE TOTAL-BODY IRRADIATION (TBI) AND HIGH-DOSE VP-16 AS CONDITIONING IN ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: MASLAK P YAHALOM J COADYLYONS N CHILDS B FRANK R GABRILOVE J MICHAELI J NIESVIZKY R PEARSE R REICH L WUEST D NIMER S
Citation: P. Maslak et al., AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (APBPCT) USING INCREASED DOSE TOTAL-BODY IRRADIATION (TBI) AND HIGH-DOSE VP-16 AS CONDITIONING IN ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML), Blood, 90(10), 1997, pp. 4565-4565
CYTARABINE WITH HIGH-DOSE MITOXANTRONE INDUCES RAPID COMPLETE REMISSIONS IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA WITHOUT THE USE OF VINCRISTINE OR PREDNISONE
Authors: WEISS M MASLAK P FELDMAN E BERMAN E BERTINO J GEE T MEGHERIAN L SEITER K SCHEINBERG D GOLDE D
Citation: M. Weiss et al., CYTARABINE WITH HIGH-DOSE MITOXANTRONE INDUCES RAPID COMPLETE REMISSIONS IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA WITHOUT THE USE OF VINCRISTINE OR PREDNISONE, Journal of clinical oncology, 14(9), 1996, pp. 2480-2485
PILOT-STUDY OF 5-AZACYTIDINE (5-AZA) AND CARBOPLATIN (CBDCA) IN PATIENTS WITH RELAPSED REFRACTORY LEUKEMIA/
Authors: KRITZ AD RAPTIS G MENENDEZBOTET C MASLAK P JAKUBOWSKI A
Citation: Ad. Kritz et al., PILOT-STUDY OF 5-AZACYTIDINE (5-AZA) AND CARBOPLATIN (CBDCA) IN PATIENTS WITH RELAPSED REFRACTORY LEUKEMIA/, American journal of hematology, 51(2), 1996, pp. 117-121
MESOLYTIC SCISSION OF C-C BONDS AS A PROBE FOR PHOTOINDUCED ELECTRON-TRANSFER REACTIONS OF QUINONES
Authors: MASLAK P CHAPMAN WH
Citation: P. Maslak et Wh. Chapman, MESOLYTIC SCISSION OF C-C BONDS AS A PROBE FOR PHOTOINDUCED ELECTRON-TRANSFER REACTIONS OF QUINONES, Journal of organic chemistry, 61(8), 1996, pp. 2647-2656
CLONOTYPIC PCR CONFIRMS MINIMAL RESIDUAL DISEASE (MRD) IN CLL NODULARPR - PRELIMINARY-RESULTS FROM A SEQUENTIAL TREATMENT CLL PROTOCOL
Authors: NOY A VERMA R RAHMAN ZU GLENN M MASLAK P WEISS M ZELENETZ AD
Citation: A. Noy et al., CLONOTYPIC PCR CONFIRMS MINIMAL RESIDUAL DISEASE (MRD) IN CLL NODULARPR - PRELIMINARY-RESULTS FROM A SEQUENTIAL TREATMENT CLL PROTOCOL, Blood, 88(10), 1996, pp. 300-300
ECONOMIC-EVALUATION OF G-CSF USE IN THE THERAPY OF ADULT ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: MASLAK P WEISS M BERMAN E TYSON D SHEINBERG D
Citation: P. Maslak et al., ECONOMIC-EVALUATION OF G-CSF USE IN THE THERAPY OF ADULT ACUTE MYELOGENOUS LEUKEMIA (AML), Blood, 88(10), 1996, pp. 827-827
CONSOLIDATION THERAPY WITH HIGH-DOSE CYCLOPHOSPHAMIDE (HDC) REDUCES MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) TREATED WITH FLUDARABINE AS INDUCTION THERAPY
Authors: WEISS M GLENN M MASLAK P RAHMAN Z MEGHERIAN L NOY A ZELENETZ A SCHEINBERG D GOLDE D
Citation: M. Weiss et al., CONSOLIDATION THERAPY WITH HIGH-DOSE CYCLOPHOSPHAMIDE (HDC) REDUCES MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) TREATED WITH FLUDARABINE AS INDUCTION THERAPY, Blood, 88(10), 1996, pp. 1911-1911
OPTICAL-PROPERTIES OF SPIROCONJUGATED CHARGE-TRANSFER DYES
Authors: MASLAK P CHOPRA A MOYLAN CR WORTMANN R LEBUS S RHEINGOLD AL YAP GPA
Citation: P. Maslak et al., OPTICAL-PROPERTIES OF SPIROCONJUGATED CHARGE-TRANSFER DYES, Journal of the American Chemical Society, 118(6), 1996, pp. 1471-1481
INTRINSIC BARRIERS OF THE ALTERNATIVE MODES OF MESOLYTIC FRAGMENTATIONS OF C-S BONDS
Authors: MASLAK P THEROFF J
Citation: P. Maslak et J. Theroff, INTRINSIC BARRIERS OF THE ALTERNATIVE MODES OF MESOLYTIC FRAGMENTATIONS OF C-S BONDS, Journal of the American Chemical Society, 118(30), 1996, pp. 7235-7236
POTENTIATION OF APOPTOSIS BY TREATMENT WITH THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL IN MITOMYCIN C-TREATED GASTRIC-CANCER CELLS
Authors: SCHWARTZ GK HAIMOVITZFRIEDMAN A DHUPAR SK EHLEITER D MASLAK P LAI L LOGANZO F KELSEN DP FUKS Z ALBINO AP
Citation: Gk. Schwartz et al., POTENTIATION OF APOPTOSIS BY TREATMENT WITH THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL IN MITOMYCIN C-TREATED GASTRIC-CANCER CELLS, Journal of the National Cancer Institute, 87(18), 1995, pp. 1394-1399
SEQUENTIAL TARGETED THERAPY FOR RELAPSED ACUTE PROMYELOCYTIC LEUKEMIAWITH ALL-TRANS-RETINOIC ACID AND ANTI-CD33 MONOCLONAL-ANTIBODY M195
Authors: JURCIC JG CARON PC MILLER WH YAO TJ MASLAK P FINN RD LARSON SM WARREL RP SCHEINBERG DA
Citation: Jg. Jurcic et al., SEQUENTIAL TARGETED THERAPY FOR RELAPSED ACUTE PROMYELOCYTIC LEUKEMIAWITH ALL-TRANS-RETINOIC ACID AND ANTI-CD33 MONOCLONAL-ANTIBODY M195, Leukemia, 9(2), 1995, pp. 244-248
THE MUTATIONAL STATUS OF P53 PROTEIN IN GASTRIC AND ESOPHAGEAL ADENOCARCINOMA CELL-LINES PREDICTS SENSITIVITY TO CHEMOTHERAPEUTIC-AGENTS
Authors: NABEYA Y LOGANZO F MASLAK P LAI L DEOLIVEIRA AR SCHWARTZ GK BLUNDELL ML ALTORKI NK KELSEN DP ALBINO AP
Citation: Y. Nabeya et al., THE MUTATIONAL STATUS OF P53 PROTEIN IN GASTRIC AND ESOPHAGEAL ADENOCARCINOMA CELL-LINES PREDICTS SENSITIVITY TO CHEMOTHERAPEUTIC-AGENTS, International journal of cancer, 64(1), 1995, pp. 37-46
BASIC FIBROBLAST GROWTH-FACTOR DELAYS DNA TOPOISOMERASE INHIBITOR-INDUCED APOPTOSIS IN K562 CHRONIC MYELOID-LEUKEMIA CELLS
Authors: CALLEJA E MENZEL T KONIG A WRAZEL L MASLAK P GABRILOVE J
Citation: E. Calleja et al., BASIC FIBROBLAST GROWTH-FACTOR DELAYS DNA TOPOISOMERASE INHIBITOR-INDUCED APOPTOSIS IN K562 CHRONIC MYELOID-LEUKEMIA CELLS, Blood, 86(10), 1995, pp. 2078-2078
INDUCTION OF APOPTOSIS OF HL-60 CELLS USING THE SHORT-RANGED ALPHA-PARTICLE EMITTING 213-BISMUTH CONJUGATED TO HUMANIZED ANTI-CD33 M195 - PROSPECTS FOR SELECTIVE SINGLE-CELL KILLING IN MYELOID-LEUKEMIA
Authors: CARON PC LAI LT MASLAK P NIKULA T JURCIC J SCHEINBERG DA
Citation: Pc. Caron et al., INDUCTION OF APOPTOSIS OF HL-60 CELLS USING THE SHORT-RANGED ALPHA-PARTICLE EMITTING 213-BISMUTH CONJUGATED TO HUMANIZED ANTI-CD33 M195 - PROSPECTS FOR SELECTIVE SINGLE-CELL KILLING IN MYELOID-LEUKEMIA, Blood, 86(10), 1995, pp. 2998-2998
A PHASE-I TRIAL OF A SINGLE HIGH-DOSE OF IDARUBICIN COMBINED WITH HIGH-DOSE CYTARABINE (ARA-C) AS INDUCTION THERAPY IN RELAPSED OR REFRACTORY ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
Authors: WEISS M MASLAK P MEGHERIAN L SCHEINBERG D
Citation: M. Weiss et al., A PHASE-I TRIAL OF A SINGLE HIGH-DOSE OF IDARUBICIN COMBINED WITH HIGH-DOSE CYTARABINE (ARA-C) AS INDUCTION THERAPY IN RELAPSED OR REFRACTORY ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL), Blood, 86(10), 1995, pp. 3131-3131
CARBON-CARBON BOND-CLEAVAGE IN RADICAL-ANIONS OF STRAINED DIPHENYLETHANE DERIVATIVES
Authors: MASLAK P NARVAEZ JN VALLOMBROSO TM
Citation: P. Maslak et al., CARBON-CARBON BOND-CLEAVAGE IN RADICAL-ANIONS OF STRAINED DIPHENYLETHANE DERIVATIVES, Journal of the American Chemical Society, 117(50), 1995, pp. 12373-12379
Risultati: 1-25 | 26-39